The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery

Clinical Endocrinology

Volumn 44, Issue 1, 1996, Pages 91-101

  Cotterill, Andrew M ^a   Mendel, Paul ^a   Holly, Jeffrey M P ^b   Gerald Timmins, A ^a   Camacho Hübner, Cecilia ^a   Hughes, Sian Cwyfan ^b   Ross, Richard M J ^a   Blum, Werner F ^c   Langford, Richard M ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; STRESS;

EID: 0030022696     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.649471.x     Document Type: Article

References (34)

1. Baxter, R.C. (1990) Circulating levels and molecular distribution of the acid-labile (a) subunit ofthe high molecular weight insulin-like growth factor-binding protein complex. Journal of Clinical Endocrinology and Metabolism, 70, 1347-1353.
2. Baxter, R.C. (1994) Insulin-like growth factor binding proteins in the human circulation: a review. Hormone Research, 42, 140-144.
3. Baxter, R.C. & Martin, J.L. (1989) Binding proteins for the insulin-like growth factors: structure, regulation and function. Progress in Growth Factor Research, 1, 49-68.
4. Blat, C., Villudy, J. & Binoux, M. (1994) In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. Journal of Clinical Investigation, 93, 2286-2290.
5. Blum, W.F., Ranke, M.B. & Bierich, J.R. (1988) A specific radioimmunoassay for insulin-like growth factor-II: the interference of IGF binding proteins can be blocked by excess IGF-I. Acta Endocrinologica, 118, 374-380.
6. Blum, W.F. & Ranke, M.B. (1991) Plasma IGFBP-3 levels as clinical indicators. In Modern Concepts of Insulin-like Growth Factors (ed. E.M. Spencer), pp. 381-393. Elsevier Science Publishing Co, New York, USA.
7. Blum, W.F., Horn, N., Kratzsch, J., Jorgensen, J.O., Juul, A., Teale, D., Mohnike, K. & Ranke, M.B. (1993) Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regualtion, 3, 100-104.
8. Camacho-Hübner, C., Busby, W.U., McCusker, R.H., Wright, G. & Clemmons, D.R. (1992) Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. Journal of Biological Chemistry, 267, 11949-11956.
9. Conover, C.A., Divertie, G.D. & Lee, P.D.K. (1993) Cortisol increases plasma insulin-like growth factor binding protein-1 in humans. Acat Endocrinogica, 128, 140-143.
10. Cotterill, A.M., Cowell C.T., Baxter, R.C., McNeil, D. & Silink, M. (1988) Regulation of the growth hormone-independent growth factor binding protein in children. Journal of Clinical Endocrinology and Metabolism, 67, 882-887.
11. Cotterill, A.M., Holly, J.M.P. & Wass, J.A.H. (1993a) The regulation of insulin-like growth factor binding protein (IGFBP)-1 during and following prolonged fasting. Clinical Endocrinology, 39, 357-362.
12. Cotterill, A.M., Holly, J.M.P., Amiel, S., Wass, J.A.H. (1993b) Suppression of endogenous insulin secretion regulates the rapid rise of insulin-like growth factor binding protein (IGFBP)-I Clinical Endocrinology, 38, 633-639.
13. Cwyfan Hughes, S.C. Cotterill, A.M., Molloy, A.R., Cassell, T.B., Braude, N., Hinds, C.J., Wass, J.A.H. & Holly, J.M.P. (1992) The induction of specific proteases for insulin-like growth factor binding proteins following coronary artery vein bypass surgery, Journal of Endocrinology, 135, 135-45.
14. Cwyfan Hughes, S.C., Wass, J.A.H. & Holly, J.M.P. (1993) Two site-specific radioimmunoassays which demonstrate the presence of proteolytically modified insulin-like growth factor-binding protein-3 in the circulation. Journal of Endocrinology, 137, 321-328.
15. Davenport, M.L., Isley, W.L., Pucilowska, J.B., Pemberton, L.B., Lyman, B., Underwood, L.E. & Clemmons, D.R. (1992) Insulin-like growth factor binding protein-3 proteolysis is induced by elective surgery. Journal of Clinical Endocrinology and Metabolism, 75, 590-595.
16. Davies, S.C., Wass, J.A.H., Ross, R., Cotterill, A.M., Buchanan, C., Coulson, V.J. & Holly, J.M.P. (1991) The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. Journal of Endocrinology, 130, 469-473.
17. Guler, H.P., Zapf, J., Schimd, C. & Froesch, E.R. (1989) Insulin-like growth factor I and II in healthy man. Estimates of half-lives and production rates. Acta Endocrinologica, 121, 753-758.
18. Hilding, A., Brismar, K., Thoren, M. & Hall, K. (1993) Glucagon stimulates insulin-like growth factor binding protein-1 secretion in healthy subjects, patients with pituitary insufficiency and patients with insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 77, 1142-1147.
19. Holly, J.M.P., Biddlecombe, R.A., Dunger, D.B., Edge, J.A., Amiel, S.A., Howell, R., Chard, T., Rees, L.H. & Wass, J.A.H. (1988) Circadian variation of GH-dependent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role lor insulin? Clinical Endocrinology, 29, 667-75.
20. Hossenlopp, P., Seurin, B., Segovia-Quinson B., Hardouin, S. & Binoux, M. (1986) Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Analytical Biochemistry, 154, 138-143.
21. Hossenlopp, P., Seurin, B., Lasarre, C., Roghani, M., Breddon, M. & Binoux, M. (1990) Evidence for enzymatic degradation of insulin-like growth factor binding proteins in the 150 kDa complex. Journal of Clinical Endocrinology and Metabolism, 71, 797-805.
22. Jyung, R.W., Mustoe, J.A., Busby, W.U. & Clemmons, D.R. (1994) Increased wound-breaking strenght induced by insulin-like growth factor-I in combination with insulin-like growth factor binding protein-1. Surgery, 115, 23-239.
23. Kupfer, S.R., Underwood, L.E., Baxter, R.C. & Clemmons, D.R. (1993) Enhancement of the anabolic effects of growth hormone and insulin-like growth factor-I by use of both agents simultaneously. Journal of Clinical Investigation, 91, 391-396.
24. Lassare, C. & Binoux, M. (1994) Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Endocrinology, 134, 1254-1262.
25. Lewitt, M.S. & Baxter, R.C. (1989) Regulation of growth hormone-independent insulin-like growth factor-binding protein (BP-28) in cultured human fetal liver explants. Journal of Clinical Endocrinology and Metabolism, 69, 246-252.
26. Miell, J.P., Taylor, A.M., Jones, J., Buchanan, C.R., Rennie, J., Sherwood, R., Leicester, R. & Ross, R.J.M. (1992) Administration of human recombinant insulin-like growth factor-I to patients following major gastrointestinal surgery. Clinical Endocrinology, 37, 542-551.
27. Orskov, H., Wolthers, T., Grofte, T., Flyvbjerg, A., Vilstrup, H. & Hamberg, O. (1994) Somatostatin-stimulated insulin-like growth factor binding protein-1 release is abolished by hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism, 78, 13-140.
28. Rosenfeld, R.G., Pham, H., Conover, C.A., Hintz, R.L. & Baxter, R.C. (1989) Structural and immunological comparison of insulin-like growth factor binding proteins of cerebrospinal and amniotic fluids. Journal of Clinical Endocrinology and Metabolism, 68, 638-646.
29. Ross, R.J.M., Miell, J.P., Freeman, E., Jones, J., Matthews, D., Preece, M. & Buchanan, C. (1991a) Critically ill patients have high basal GH levels with attenuated oscillatory activity associated with low levels of IGF-I. Clinical Endocrinology, 35, 47-54.
30. Ross, R.J.M., Miell, J.P. & Buchanan, C. (1991b) Avoiding autocannibalism. Consider growth hormone and insulin-like growth factor-I. British Medical Journal, 303, 1147-1148.
31. Ross, R.J.M., Rodriques-Arnao, J., Donaghy, A., Bentham, J., Clark, A., Holly, J.M.P., Williams, R. & Gimson, A. (1994) Expression of IGFBP-I in normal and cirrhotic human livers. Journal of Endocrinology, 141, 377-382.
32. Unterman, T.G., Oehler, D.T., Murphy, L.J. & Lacson R.G. (1991) Multihormonal regulation of insulin-like growth factor-binding protein-1 in rat H4EIIE hepatoma cells: the dominant role of insulin. Endocrinology, 128, 2693-2701.
33. Wilmore, D.W. (1991) Catabolic illness: strategies for enhancing recovery. New England Journal of Medicine, 325, 695-702.
34. Zapf, J. Hauri, C., Futo, E., Hussain, M.A., Rutishauser, J., Maack, C.A. & Froesch, E.R. (1995) Intravenously injected insulin-like growth factor (IGF-)-I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectiomized, but not normal rats. Journal of Clinical Investigation, 95, 179-186.